Zai Lab Ltd (ZLAB)

128.64 +2.25  +1.78% NASDAQ Sep 17, 16:00 128.22 0.00  0.00% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All ZLAB News


View All Events


Date Type Description
11/15/2021 Earnings Results Q3 2021 Earnings Results
11/15/2021 08:00 EST Earnings Calls Q3 2021 Earnings Call
08/10/2021 Earnings Results Q2 2021 Earnings Results
08/10/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
06/24/2021 08:00 EST AGM 2020 Annual General Meeting
05/10/2021 Earnings Results Q1 2021 Earnings Results
05/10/2021 08:00 EST Earnings Calls Q1 2021 Earnings Call
03/01/2021 Earnings Results Q4 2020 Earnings Results
03/01/2021 08:00 EST Earnings Calls Q4 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. The other product candidate includes Fugan, ZL-2302, and ZL-1101. The company operates through the segment being Developing and commercializing proprietary therapeutics.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Large Cap/Growth
  • Next Earnings Release: Nov. 15, 2021
  • Last Earnings Release: Aug. 10, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
CHIH Global X MSCI China Health Care ETF 5.06%
ZCH.TO BMO China Equity ETF 2.76%
KURE KraneShares MSCI All China Hlth Care ETF 2.63%
GERM ETFMG Treatments Testing and Adv ETF 2.49%
PGJ Invesco Golden Dragon China ETF 2.40%
BEXUX Baron Emerging Markets R6 2.22%
BGLUX Baron Global Advantage R6 2.19%
CHNA Loncar China BioPharma ETF 1.96%
FKBSX Federated Hermes Kaufmann Small Cap B 1.95%
KAUBX Federated Hermes Kaufmann B 1.91%
CNWFX American Funds New World 529F 1.42%
BGEHX Baillie Gifford Emerging Markets Eqs 2 1.29%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.